vs

Side-by-side financial comparison of BankUnited, Inc. (BKU) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

BankUnited, Inc. is the larger business by last-quarter revenue ($288.2M vs $197.9M, roughly 1.5× REPLIGEN CORP). On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs 9.0%). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs 9.2%).

BankUnited, Inc. is the bank holding company of BankUnited, N.A., a national bank founded in 1984 and headquartered in Miami Lakes, Florida. The company operates in Florida; the regions in and around Atlanta, Georgia; Dallas, Texas; Morristown, New Jersey; Charlotte, North Carolina; and in the New York metropolitan area. BankUnited also offers certain commercial lending and deposit products through national platforms and has total assets of $35.0 billion as of December 31, 2025

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

BKU vs RGEN — Head-to-Head

Bigger by revenue
BKU
BKU
1.5× larger
BKU
$288.2M
$197.9M
RGEN
Growing faster (revenue YoY)
RGEN
RGEN
+4.7% gap
RGEN
13.6%
9.0%
BKU
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
9.2%
BKU

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BKU
BKU
RGEN
RGEN
Revenue
$288.2M
$197.9M
Net Profit
$13.3M
Gross Margin
52.5%
Operating Margin
31.2%
9.0%
Net Margin
6.7%
Revenue YoY
9.0%
13.6%
Net Profit YoY
143.9%
EPS (diluted)
$0.89
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BKU
BKU
RGEN
RGEN
Q4 25
$288.2M
$197.9M
Q3 25
$275.7M
$188.8M
Q2 25
$273.9M
$182.4M
Q1 25
$255.4M
$169.2M
Q4 24
$264.5M
$174.1M
Q3 24
$257.0M
$154.9M
Q2 24
$250.2M
$154.1M
Q1 24
$241.7M
$151.3M
Net Profit
BKU
BKU
RGEN
RGEN
Q4 25
$13.3M
Q3 25
$71.9M
$14.9M
Q2 25
$68.8M
$14.9M
Q1 25
$58.5M
$5.8M
Q4 24
$-30.3M
Q3 24
$61.5M
$-654.0K
Q2 24
$53.7M
$3.3M
Q1 24
$48.0M
$2.1M
Gross Margin
BKU
BKU
RGEN
RGEN
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
BKU
BKU
RGEN
RGEN
Q4 25
31.2%
9.0%
Q3 25
35.5%
8.9%
Q2 25
34.3%
7.6%
Q1 25
31.4%
3.9%
Q4 24
35.2%
-17.7%
Q3 24
32.4%
-5.1%
Q2 24
29.2%
1.0%
Q1 24
27.8%
1.3%
Net Margin
BKU
BKU
RGEN
RGEN
Q4 25
6.7%
Q3 25
26.1%
7.9%
Q2 25
25.1%
8.2%
Q1 25
22.9%
3.4%
Q4 24
-17.4%
Q3 24
23.9%
-0.4%
Q2 24
21.5%
2.2%
Q1 24
19.8%
1.4%
EPS (diluted)
BKU
BKU
RGEN
RGEN
Q4 25
$0.89
$0.24
Q3 25
$0.95
$0.26
Q2 25
$0.91
$0.26
Q1 25
$0.78
$0.10
Q4 24
$0.91
$-0.55
Q3 24
$0.81
$-0.01
Q2 24
$0.72
$0.06
Q1 24
$0.64
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BKU
BKU
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$217.8M
$767.6M
Total DebtLower is stronger
$319.7M
$542.2M
Stockholders' EquityBook value
$3.1B
$2.1B
Total Assets
$35.0B
$2.9B
Debt / EquityLower = less leverage
0.10×
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BKU
BKU
RGEN
RGEN
Q4 25
$217.8M
$767.6M
Q3 25
$559.5M
$748.7M
Q2 25
$801.3M
$708.9M
Q1 25
$443.7M
$697.2M
Q4 24
$491.1M
$757.4M
Q3 24
$889.9M
$784.0M
Q2 24
$433.5M
$809.1M
Q1 24
$421.2M
$780.6M
Total Debt
BKU
BKU
RGEN
RGEN
Q4 25
$319.7M
$542.2M
Q3 25
$320.4M
$537.9M
Q2 25
$708.9M
Q1 25
$709.1M
Q4 24
$708.6M
$525.6M
Q3 24
$708.7M
Q2 24
$708.8M
Q1 24
$709.0M
Stockholders' Equity
BKU
BKU
RGEN
RGEN
Q4 25
$3.1B
$2.1B
Q3 25
$3.0B
$2.1B
Q2 25
$3.0B
$2.1B
Q1 25
$2.9B
$2.0B
Q4 24
$2.8B
$2.0B
Q3 24
$2.8B
$2.0B
Q2 24
$2.7B
$2.0B
Q1 24
$2.6B
$2.0B
Total Assets
BKU
BKU
RGEN
RGEN
Q4 25
$35.0B
$2.9B
Q3 25
$35.1B
$2.9B
Q2 25
$35.5B
$2.9B
Q1 25
$34.8B
$2.9B
Q4 24
$35.2B
$2.8B
Q3 24
$35.8B
$2.8B
Q2 24
$35.4B
$2.9B
Q1 24
$35.1B
$2.8B
Debt / Equity
BKU
BKU
RGEN
RGEN
Q4 25
0.10×
0.26×
Q3 25
0.11×
0.26×
Q2 25
0.24×
Q1 25
0.24×
Q4 24
0.25×
0.27×
Q3 24
0.25×
Q2 24
0.26×
Q1 24
0.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BKU
BKU
RGEN
RGEN
Operating Cash FlowLast quarter
$358.6M
$25.7M
Free Cash FlowOCF − Capex
$17.6M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BKU
BKU
RGEN
RGEN
Q4 25
$358.6M
$25.7M
Q3 25
$99.7M
$48.1M
Q2 25
$117.6M
$28.6M
Q1 25
$16.4M
$15.0M
Q4 24
$433.8M
$39.2M
Q3 24
$46.1M
$49.3M
Q2 24
$135.7M
$42.2M
Q1 24
$66.5M
$44.7M
Free Cash Flow
BKU
BKU
RGEN
RGEN
Q4 25
$17.6M
Q3 25
$43.4M
Q2 25
$21.5M
Q1 25
$11.4M
Q4 24
$33.6M
Q3 24
$42.3M
Q2 24
$37.4M
Q1 24
$36.4M
FCF Margin
BKU
BKU
RGEN
RGEN
Q4 25
8.9%
Q3 25
23.0%
Q2 25
11.8%
Q1 25
6.8%
Q4 24
19.3%
Q3 24
27.3%
Q2 24
24.3%
Q1 24
24.0%
Capex Intensity
BKU
BKU
RGEN
RGEN
Q4 25
4.1%
Q3 25
2.5%
Q2 25
3.9%
Q1 25
2.1%
Q4 24
3.2%
Q3 24
4.5%
Q2 24
3.1%
Q1 24
5.5%
Cash Conversion
BKU
BKU
RGEN
RGEN
Q4 25
1.93×
Q3 25
1.39×
3.23×
Q2 25
1.71×
1.92×
Q1 25
0.28×
2.57×
Q4 24
Q3 24
0.75×
Q2 24
2.53×
12.70×
Q1 24
1.39×
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons